Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management
Dale Liebenberg, Bhavna G. Gordhan, Bavesh D Kana
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

How macrophage heterogeneity affects tuberculosis disease and therapy
David G. Russell, Nelson V. Simwela, Joshua T. Mattila, et al.
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 4
Chitosan/Alginate-Based Nanoparticles for Antibacterial Agents Delivery
Nasrul Wathoni, Yedi Herdiana, Cecep Suhandi, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 5021-5044
Open Access | Times Cited: 11
Transmission characteristics in Tuberculosis by WGS: nationwide cross-sectional surveillance in China
Dongxin Liu, Fei Huang, Yaru Li, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
Kona Chowdhury, Rahnuma Ahmad, Susmita Sinha, et al.
Cureus (2023)
Open Access | Times Cited: 22
Bioactives from medicinal herb against bedaquiline resistant tuberculosis: Removing the Dark Clouds from the Horizon
Rahul Singh, Souvik Manna, Hemraj Nandanwar, et al.
Microbes and Infection (2023) Vol. 26, Iss. 3, pp. 105279-105279
Closed Access | Times Cited: 20
Innovative laboratory methods for improved tuberculosis diagnosis and drug-susceptibility testing
Nathan Mugenyi, Nelson Ssewante, Joseph Baruch Baluku, et al.
Frontiers in Tuberculosis (2024) Vol. 1
Open Access | Times Cited: 8
Prevalence and patterns of drug-resistant Mycobacterium tuberculosis in newly diagnosed patients in China: A systematic review and meta-analysis
Cong Jin, Yuting Wu, Jiangpo Chen, et al.
Journal of Global Antimicrobial Resistance (2024) Vol. 38, pp. 292-301
Open Access | Times Cited: 5
Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision
Maria Vittoria Ristori, Valerio Guarrasi, Paolo Soda, et al.
Genes (2024) Vol. 15, Iss. 7, pp. 908-908
Open Access | Times Cited: 5
Telemedicine as a tool to prevent multi-drug resistant tuberculosis in poor resource settings: Lessons from Nigeria
Kikelomo Sabainah Olowoyo, Deborah Tolulope Esan, Benedict Tolulope Adeyanju, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases (2024) Vol. 35, pp. 100423-100423
Open Access | Times Cited: 4
Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
Talia Greenstein, Bree B. Aldridge
Frontiers in Cellular and Infection Microbiology (2023) Vol. 12
Open Access | Times Cited: 10
Enhanced detection of Mycobacterium Tuberculosis using nanogold-based silver staining enhancement
Lili Quan, Q. Yang, Zhu Jin, et al.
Bio-Medical Materials and Engineering (2025)
Closed Access
Progress in the role of nanoparticles in the diagnosis and treatment of bone and joint tuberculosis
Yitong Ding, B P Li, Yangfei Yi, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Regulation of FOXM1 by HDAC3 Inhibition Ameliorates Macrophage Endoplasmic Reticulum stress and Apoptosis in Mycobacterium tuberculosis Infection
Jin-qi Hao, Lanwei Zhang, Jia Jia Qi, et al.
Immunobiology (2025) Vol. 230, Iss. 2, pp. 152879-152879
Open Access
AUMENTO DA INCIDÊNCIA DA TUBERCULOSE NO BRASIL: ANÁLISE EPIDEMIOLÓGICA ENTRE 2019 E 2023 E IDENTIFICAÇÃO DOS FATORES DETERMINANTES NA PREVALÊNCIA
Jeferson Ávila Souza, Ivone B. Oliveira, Fernando Malachias de Andrade Bergamo, et al.
Revista Contemporânea (2025) Vol. 5, Iss. 2, pp. e7446-e7446
Closed Access
Outcomes of Treating Tuberculosis Patients with Drug-Resistant Tuberculosis, Human Immunodeficiency Virus, and Nutritional Status: The Combined Impact of Triple Challenges in Rural Eastern Cape
Ntandazo Dlatu, Lindiwe Modest Faye, Teke Apalata
International Journal of Environmental Research and Public Health (2025) Vol. 22, Iss. 3, pp. 319-319
Open Access
Genetic polymorphism of the NF-kB1 р105/р50 processing region in pulmonary tuberculosis
A. V. Meyer, BA Thorenko, D. O. Imekina, et al.
Bulletin of Russian State Medical University (2025), Iss. 2025(1)
Open Access
Tuberculosis multirresistente en adolescente: A propósito de un caso
Lorena García Agudelo, Julio César Velasco Castro, Mónica Liseth Holguín Barrera
Infectio (2025), pp. 51-53
Open Access
Impact of rpoB gene mutations and Rifampicin-resistance levels on treatment outcomes in Rifampicin-resistant tuberculosis
Maria Jose Vadakunnel, Vijayalakshmi Jawaharlal Nehru, Usharani Brammacharry, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Host-Mediated Antimicrobial Effects and NLRP3 Inflammasome Modulation by Caulerpin and Its Derivatives in Macrophage Models of Mycobacterial Infections
Maria Gabriella S. Sidrônio, Maria Eugênia G. de Freitas, Daniel Magalhães, et al.
Microorganisms (2025) Vol. 13, Iss. 3, pp. 561-561
Open Access
A Novel Rapid Detection Method for Mycobacterium tuberculosis Based on Scattering-Light Turbidity Using Loop-Mediated Isothermal Amplification
Meimei Zeng, Xinru Wang, Zifeng Tan, et al.
Biosensors (2025) Vol. 15, Iss. 3, pp. 162-162
Open Access
Treatment Adherence and Outcomes in Patients with Tuberculosis Treated with Telemedicine: A Scoping Review
Kikelomo Sabainah Olowoyo, Deborah Tolulope Esan, Paul Olowoyo, et al.
Tropical Medicine and Infectious Disease (2025) Vol. 10, Iss. 3, pp. 78-78
Open Access
Mannosamine-Engineered Nanoparticles for Precision Rifapentine Delivery to Macrophages: Advancing Targeted Therapy Against Mycobacterium Tuberculosis
Haopeng Luan, Cong Peng, Parhat Yasin, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 2081-2102
Open Access
Stem cell-based therapies and organoid models: Advancing tuberculosis treatment and research
James D. Tang
Deleted Journal (2025), pp. 1-12
Closed Access
GLOBAL TRENDS, RISK FACTORS, AND CHALLENGES IN DRUG-RESISTANT TUBERCULOSIS: A SYSTEMATIC REVIEW OF ANTIMICROBIAL RESISTANCE PATTERNS AND DETERMINANTS
Ruth Chipampe Kafwanka, Rogers Chilyabanyama, Richard Chirwa, et al.
(2025)
Closed Access
Genotypic drug resistance and transmission clusters of Mycobacterium tuberculosis isolates among Ethiopian returnees from Saudi Arabia
Melaku Tilahun, Abay Atnafu, Tewodros Tariku Gebresilase, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0318743-e0318743
Open Access
Page 1 - Next Page

Scroll to top